Aryl aminopyrimidines as dual MerTK and TYRO3 inhibitors and methods thereof
US-12448365-B2 · Oct 21, 2025 · US
This page is not indexed by search engines while we improve data quality.
Frye Stephen patents
Frye Stephen is listed as an inventor on 29 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Frye Stephen |
| Total patents | 29 |
| First publication | Oct 8, 2015 |
| Latest publication | Oct 21, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Aryl aminopyrimidines as dual mertk and tyro3 inhibitors and methods thereof
US-2022411407-A1 · Dec 29, 2022 · US
Inhibitors of microbial beta-glucuronidase enzymes and uses thereof
US-11339178-B2 · May 24, 2022 · US
Method and apparatus for reducing carryover of reagents and samples in analytical testing
US-10656169-B2 · May 19, 2020 · US
Inhibitors of microbial beta-glucuronidase enzymes and uses thereof
US-2019330237-A1 · Oct 31, 2019 · US
Pyrrolopyrimidine compounds for the treatment of cancer
US-10179133-B2 · Jan 15, 2019 · US
Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
US-10004755-B2 · Jun 26, 2018 · US
Pyrrolopyrimidine compounds for the treatment of cancer
US-2018104247-A1 · Apr 19, 2018 · US
Pyrrolopyrimidine compounds for the treatment of cancer
US-9795606-B2 · Oct 24, 2017 · US
Pyrazolopyrimidine compounds for the treatment of cancer
US-9744172-B2 · Aug 29, 2017 · US
Recent patents
Latest publications not already listed above.
Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
US-2017136043-A1 · May 18, 2017 · US
Therapeutic uses of selected pyrimidine compounds with anti-Mer tyrosine kinase activity
US-9649309-B2 · May 16, 2017 · US
MerTK-specific pyrazolopyrimidine compounds
US-9603850-B2 · Mar 28, 2017 · US
Method and apparatus for reducing carryover of reagents and samples in analytical testing
US-2017082646-A1 · Mar 23, 2017 · US
Pyrazolopyrimidine compounds for the treatment of cancer
US-9562047-B2 · Feb 7, 2017 · US
Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
US-9555031-B2 · Jan 31, 2017 · US
Therapeutic uses of selected pyrazolopyrimidine compounds with anti-Mer tyrosine kinase activity
US-9555030-B2 · Jan 31, 2017 · US
Pyrazolopyrimidine compounds for the treatment of cancer
US-2016279132-A1 · Sep 29, 2016 · US
Pyrrolopyrimidine compounds for the treatment of cancer
US-2016151372-A1 · Jun 2, 2016 · US
Pyrazolopyrimidine compounds for the treatment of cancer
US-9290499-B2 · Mar 22, 2016 · US
Pyrrolopyrimidine compounds for the treatment of cancer
US-9273056-B2 · Mar 1, 2016 · US
Mertk-specific pyrrolopyrimidine compounds
US-2015291606-A1 · Oct 15, 2015 · US
Therapeutic uses of selected pyrazolopyrimidine compounds with anti-mer tyrosine kinase activity
US-2015290212-A1 · Oct 15, 2015 · US
Therapeutic uses of selected pyrimidine compounds with anti-mer tyrosine kinase activity
US-2015290194-A1 · Oct 15, 2015 · US
Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity
US-2015290197-A1 · Oct 15, 2015 · US
Mertk-specific pyrazolopyrimidine compounds
US-2015291605-A1 · Oct 15, 2015 · US
Mertk-specific pyrimidine compounds
US-2015291609-A1 · Oct 15, 2015 · US
Functionally selective ligands of dopamine D2 receptors
US-9156822-B2 · Oct 13, 2015 · US
Pyrazolopyrimidine compounds for the treatment of cancer
US-2015284392-A1 · Oct 8, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ North Carolina Chapel Hill | 16 |
| Univ North Carolina | 11 |
| Frye Stephen | 2 |
| Siemens Healthcare Diagnostics Inc | 2 |
| Wang Xiaodong | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 24 |
| C07D487/04 | 22 |
| A61K31/519 | 20 |
| A61K31/5377 | 20 |
| A61P43/00 | 17 |